Lithium improves HIV-associated neurocognitive impairment

No abstract is available for this paper.

• Publication year

  2006

• Venue

  AIDS (London)

• Publication date

  2006-09-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.aids.0000244208.49123.1bPMID 16954730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lithium salts in AIDS and AIDS-related dementia.

  2025influential reference
• Suppression of human immunodeficiency virus replication in human brain tissue by nucleoside reverse transcriptase inhibitors

  2011cited by this paper
• Plasma levels of leptin and endogenous immune modulators during treatment with carbamazepine or lithium

  2005cited by this paper
• GSK3 inhibitors: development and therapeutic potential

  2004cited by this paper
• Predictive Validity of Global Deficit Scores in Detecting Neuropsychological Impairment in HIV Infection

  2004cited by this paper
• HIV dementia: an evolving disease.

  2004cited by this paper
• Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

  2004cited by this paper
• The impact of HIV-associated neuropsychological impairment on everyday functioning

  2004cited by this paper
• Interrater Reliability of Clinical Ratings and Neurocognitive Diagnoses in HIV

  2004cited by this paper
• Lithium ameliorates HIV-gp120-mediated neurotoxicity.

  2002cited by this paper
• Fibroblast Growth Factor 1 Regulates Signaling via the Glycogen Synthase Kinase-3β Pathway

  2002cited by this paper
• HIV‐1 Tat‐Mediated Activation of Glycogen Synthase Kinase‐3β Contributes to Tat‐Mediated Neurotoxicity

  1999influential reference
• Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.

  1999cited by this paper
• Neuropsychological performance of HIV-1 infected men with major depression

  1997cited by this paper
• The HNRC 500-Neuropsychology of Hiv infection at different disease stages

  1995cited by this paper
• Validity of the Quality of Well-Being Scale for Persons With Human Immunodeficiency Virus Infection

  1995cited by this paper
• Effect of lithium in murine immunodeficiency virus infected animals.

  1993cited by this paper

• An Overview of HIV-associated Neurocognitive Disorder in South Africa

  2025cites this paper
• HIV Cerebrospinal Fluid Escape: Interventions for the Management, Current Evidence and Future Perspectives

  2025cites this paper
• Lithium attenuates HIV-1 latency reversal in an autophagy-independent way

  2025cites this paper
• Lithium’s renaissance: From psychiatric staple to multifaceted medical marvel

  2024cites this paper
• Advances in assessment and cognitive neurorehabilitation of HIV-related neurocognitive impairment

  2024cites this paper
• Behavioral and histological assessment of a novel treatment of neuroHIV in humanized mice

  2023cites this paper
• Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial

  2023influential citation
• Developments in Neuroprotection for HIV-Associated Neurocognitive Disorders (HAND)

  2022cites this paper
• HIV and Mental Health in Men

  2021cites this paper
• Clinical Treatment Options and Randomized Clinical Trials for Neurocognitive Complications of HIV Infection: Combination Antiretroviral Therapy, Central Nervous System Penetration Effectiveness, and Adjuvants.

  2021cites this paper
• HIV Associated Neurocognitive Disorders Subsidence Through Citalopram Addition in Anti-retroviral Therapy (HANDS-CARE): A Concept Note

  2021cites this paper
• Synapto-protective effect of lithium on HIV-1 Tat-induced synapse loss in rat hippocampal cultures

  2021cites this paper
• Cognitive and Neurologic Rehabilitation Strategies for Central Nervous System HIV Infection

  2020cites this paper
• Disparate Effects of Lithium and a GSK-3 Inhibitor on Neuronal Oscillatory Activity in Prefrontal Cortex and Hippocampus

  2018cites this paper
• Human Immunodeficiency Virus (HIV)-Associated CD8 Encephalitis

  2018cites this paper
• A Complex Case of Psychiatric Issues Associated with HIV Disorder

  2018cites this paper
• Antiviral effect of lithium chloride on replication of avian leukosis virus subgroup J in cell culture

  2018cites this paper
• Treatment of HIV associated neurocognitive disorders

  2018cites this paper
• Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial

  2017cites this paper
• Global Virology II - HIV and NeuroAIDS

  2017influential citation
• Head and heart in treated HIV infection

  2017cites this paper
• Transdermal rivastigmine for HIV-associated cognitive impairment: A randomized pilot study

  2017cites this paper
• Therapeutic Considerations in HIV-Associated Neurocognitive Disorders

  2017cites this paper
• Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS

  2017cites this paper
• The neurobiology of HIV and its impact on cognitive reserve: A review of cognitive interventions for an aging population.

  2016cites this paper
• Moderate to severe HIV-associated neurocognitive impairment

  2016influential citation
• AIDS: Acquired Immune-Deficiency Syndrome

  2015cites this paper
• Are Structural Changes Induced by Lithium in the HIV Brain Accompanied by Changes in Functional Connectivity?

  2015cites this paper
• LiCl inhibits PRRSV infection by enhancing Wnt/β-catenin pathway and suppressing inflammatory responses.

  2015influential citation
• Genetic, Transcriptomic, and Epigenetic Studies of HIV-Associated Neurocognitive Disorder

  2014cites this paper
• Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.

  2014cites this paper
• Endogenous Retrovirus-K and Nervous System Diseases

  2014cites this paper
• HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients

  2014cites this paper
• The mechanism of HIV-1 Tat-induced changes in NMDA receptor function

  2014cites this paper
• Impact of lithium alone and in combination with antidepressants on cytokine production in vitro

  2014cites this paper
• Treatment of Psychiatric Disorders in HIV

  2014cites this paper
• HIV AND OPIATES-MEDIATED NEUROTOXICITY: GSK3β IS A POTENTIAL THERAPEUTIC TARGET

  2014cites this paper
• Human endogenous retroviruses and the nervous system.

  2014cites this paper
• Excitotoxicity in HIV Associated Neurocognitive Disorders

  2014cites this paper
• Adjuvant therapies for HIV-associated neurocognitive disorders

  2014cites this paper
• Psychotropic Drugs and HIV

  2014cites this paper
• Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders

  2014cites this paper
• Rivastigmine for HIV-associated neurocognitive disorders

  2013cites this paper
• Prepulse Inhibition in HIV-Associated Neurocognitive Disorders

  2013cites this paper
• Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation?

  2013cites this paper
• Cognitive Neurorehabilitation of HIV-associated Neurocognitive Disorders: A Qualitative Review and Call to Action

  2013cites this paper
• Prevention, Rehabilitation, and Mitigation Strategies of Cognitive Deficits in Aging with HIV: Implications for Practice and Research

  2013cites this paper
• The Role of Glycogen Synthase Kinase 3 Beta in Neuroinflammation and Pain.

  2013cites this paper
• The Role of Neuroplasticity and Cognitive Reserve in Aging With HIV: Recommendations for Cognitive Protection and Rehabilitation

  2013cites this paper
• Assessing and Treating Forgetfulness and Cognitive Problems in Adults With HIV

  2013cites this paper
• Mechanisms of HIV-associated neurotoxicity: Tat-induced synapse loss and recovery

  2013cites this paper
• Central Nervous System Infection by HIV-1: Special Emphasis to NeuroAIDS in India

  2012cites this paper
• Chronic Lithium Feeding Reduces Upregulated Brain Arachidonic Acid Metabolism in HIV-1 Transgenic Rat

  2012cites this paper
• Neuropsychiatric complications of aging with HIV

  2012cites this paper
• Psychopharmacological treatments in HIV patients under antiretroviral therapy.

  2012cites this paper
• Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.

  2012cites this paper
• Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV‐1 Tat

  2012cites this paper
• HIV treatment: mechanisms of neurotoxicity and implications for targeted therapy

  2012cites this paper
• [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].

  2011cites this paper
• Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain

  2011cites this paper
• Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats

  2011cites this paper
• HIV-associated neurocognitive disorders: a changing pattern

  2011cites this paper
• Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients

  2011cites this paper
• Neuroimmune Pharmacology of Neurodegenerative and Mental Diseases

  2011cites this paper
• Neuropatogénesis inducida por el virus del sida: estrategias terapéuticas frente a la neurodegeneración inducida por la glucoproteína gp120/Tat en el sistema nervioso central

  2011cites this paper
• The neurobiology of HIV dementia: implications for practice in South Africa.

  2011cites this paper
• Neuronal injury in simian immunodeficiency virus and other animal models of neuroAIDS

  2011cites this paper
• The Role of Adaptive Stress Responses in HIV Replication and Macrophage-Mediated Neurotoxicity

  2011cites this paper
• [HIV associated neurocognitive disorders].

  2011cites this paper
• Role of β-Catenin/TCF-4 Signaling in HIV Replication and Pathogenesis: Insights to Informing Novel Anti-HIV Molecular Therapeutics

  2011cites this paper
• HIV-1 infection and cognitive impairment in the cART era: a review.

  2011cites this paper
• Mechanisms of lithium ’ s neuroprotective actions 2 . 1 Lithium as a multi-functional neuroprotectant

  2011cites this paper
• Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders.

  2010cites this paper
• Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.

  2010cites this paper
• Leukocyte transmigration across the blood-brain barrier: perspectives on neuroAIDS.

  2010cites this paper
• Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation

  2010cites this paper
• Brain dysfunction in the era of combination antiretroviral therapy: implications for the treatment of the aging population of HIV-infected individuals.

  2010cites this paper
• Neurocognitive Impairment and HIV Risk Factors: A Reciprocal Relationship

  2010cites this paper
• Neurocognitive disorders in young adults commencing highly active anti-retroviral treatment in the Western Cape

  2010cites this paper
• Treatment considerations for psychiatric syndromes associated with HIV infection

  2010cites this paper
• Neurologic complications of HIV disease and their treatment.

  2010cites this paper
• HERVs in Neuropathogenesis

  2010cites this paper
• HIV Infection and the Central Nervous System: A Primer

  2009cites this paper
• Lithium therapy for human immunodeficiency virus type 1-associated neurocognitive impairment

  2009cites this paper
• HIV-1-Associated Neurocognitive Disorders in the HAART Era

  2009cites this paper
• HIV infection and psychiatric illness.

  2009cites this paper
• A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.

  2009cites this paper
• Adjunctive Therapy for Long-Term Support of Cognitive Impairment

  2009influential citation
• Glycogen synthase kinase-3β (GSK-3β) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus—mediated neurotoxicity in primary human neurons

  2009influential citation
• Molecular Pathology of Neuro-AIDS (CNS-HIV)

  2009influential citation
• The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis.

  2009cites this paper
• Active (cid:2) -Catenin Signaling Is an Inhibitory Pathway for Human Immunodeficiency Virus Replication in Peripheral Blood Mononuclear Cells (cid:1)

  2008cites this paper
• Psychopharmacology in HIV-Infected Patients

  2008cites this paper
• Developing neuroprotective strategies for treatment of HIV-associated neurocognitive dysfunction.

  2008cites this paper
• Neurobiology of HIV

  2008cites this paper
• Preventing brain damage in HIV infection

  2008cites this paper
• Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders

  2008cites this paper
• Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death

  2008cites this paper
• HIV and antiretroviral therapy in the brain: neuronal injury and repair

  2008cites this paper
• Chemokine receptors and neurotrophic factors: Potential therapy against aids dementia?

  2008cites this paper